Mai E. Shoman

976 total citations
40 papers, 759 citations indexed

About

Mai E. Shoman is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Mai E. Shoman has authored 40 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 15 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Mai E. Shoman's work include Synthesis and biological activity (16 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Mai E. Shoman is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Mai E. Shoman collaborates with scholars based in Egypt, Saudi Arabia and United States. Mai E. Shoman's co-authors include Omar M. Aly, Mohamed Abdel‐Aziz, Eman A. M. Beshr, Gamal El‐Din A. Abuo‐Rahma, Al‐Shaimaa F. Ahmed, Salah A. Abdel‐Aziz, Tamer S. Kaoud, Atsushi Narumi, Hiroyuki Konno and Hassan H. Farag and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Mai E. Shoman

39 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mai E. Shoman Egypt 17 451 245 84 80 62 40 759
Michel Boisbrun France 19 397 0.9× 337 1.4× 120 1.4× 43 0.5× 78 1.3× 40 767
Luigi Margarucci Italy 17 274 0.6× 373 1.5× 105 1.3× 43 0.5× 40 0.6× 31 726
Süreyya Ölgen Türkiye 21 532 1.2× 341 1.4× 90 1.1× 71 0.9× 72 1.2× 67 921
Ghaneya S. Hassan Egypt 19 956 2.1× 258 1.1× 259 3.1× 97 1.2× 97 1.6× 39 1.2k
Krishnendu Bera India 16 526 1.2× 262 1.1× 47 0.6× 41 0.5× 72 1.2× 28 793
Zeki Topçu Türkiye 16 218 0.5× 334 1.4× 40 0.5× 17 0.2× 53 0.9× 33 596
Piotr Świątek Poland 16 706 1.6× 412 1.7× 112 1.3× 105 1.3× 88 1.4× 53 1.0k
Shahid M. Nayeem India 14 135 0.3× 336 1.4× 57 0.7× 81 1.0× 101 1.6× 40 618
Laura Guasch Spain 19 210 0.5× 528 2.2× 93 1.1× 279 3.5× 78 1.3× 29 883
Marco Tatò Italy 13 208 0.5× 488 2.0× 59 0.7× 89 1.1× 33 0.5× 30 849

Countries citing papers authored by Mai E. Shoman

Since Specialization
Citations

This map shows the geographic impact of Mai E. Shoman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai E. Shoman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai E. Shoman more than expected).

Fields of papers citing papers by Mai E. Shoman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai E. Shoman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai E. Shoman. The network helps show where Mai E. Shoman may publish in the future.

Co-authorship network of co-authors of Mai E. Shoman

This figure shows the co-authorship network connecting the top 25 collaborators of Mai E. Shoman. A scholar is included among the top collaborators of Mai E. Shoman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai E. Shoman. Mai E. Shoman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdel‐Aziz, Salah A., Kamal Abdelrahman, Atsushi Narumi, et al.. (2025). Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 130. 130416–130416.
2.
Shoman, Mai E., et al.. (2025). Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator. Scientific Reports. 15(1). 19207–19207. 4 indexed citations
3.
Shoman, Mai E., et al.. (2024). An overview of the most used synthetic pathways of 1,2,4-triazolo[1,5-a]pyrimidines. Results in Chemistry. 12. 101903–101903. 2 indexed citations
4.
Abdel‐Aziz, Salah A., Montaser Sh. A. Shaykoon, Atsushi Narumi, et al.. (2024). Development of 1,5-diarylpyrazoles as EGFR/JNK-2 dual inhibitors: design, synthesis, moleecular docking, and bioactivity evaluation. Bioorganic & Medicinal Chemistry Letters. 102. 129673–129673. 5 indexed citations
5.
Shoman, Mai E., et al.. (2024). Anti-Tumor Activity of Indole: A Review. Letters in Drug Design & Discovery. 21(16). 3332–3348. 1 indexed citations
6.
Fahim, John Refaat, Ahmed E. Allam, Mai E. Shoman, et al.. (2023). Studies on the Nonalkaloidal Secondary Metabolites of Hippeastrum vittatum (L’Her.) Herb. Bulbs. ACS Omega. 8(30). 26749–26761. 4 indexed citations
7.
Abou‐Taleb, Heba A., et al.. (2023). Exploration of the Safety and Solubilization, Dissolution, Analgesic Effects of Common Basic Excipients on the NSAID Drug Ketoprofen. Pharmaceutics. 15(2). 713–713. 15 indexed citations
8.
Bender, Onur, İsmail Çeli̇k, Arzu Atalay, et al.. (2023). Vanillin-Based Indolin-2-one Derivative Bearing a Pyridyl Moiety as a Promising Anti-Breast Cancer Agent via Anti-Estrogenic Activity. ACS Omega. 8(7). 6968–6981. 26 indexed citations
9.
10.
El‐Saghier, Ahmed M. M., et al.. (2021). Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities. Molecular Diversity. 26(3). 1743–1759. 30 indexed citations
11.
Shoman, Mai E., Maha M. Abdel‐Fattah, Mohamed Badr, et al.. (2021). New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors. Pharmaceuticals. 14(11). 1114–1114. 13 indexed citations
12.
Shoman, Mai E., et al.. (2020). New nicotinic acid-based 3,5-diphenylpyrazoles: design, synthesis and antihyperlipidemic activity with potential NPC1L1 inhibitory activity. Molecular Diversity. 25(2). 673–686. 18 indexed citations
13.
14.
Beshr, Eman A. M., et al.. (2018). Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 146. 79–92. 32 indexed citations
15.
Abbas, Samar H., Amer Ali Abd El‐Hafeez, Mai E. Shoman, Monica M. Montano, & Heba A. Hassan. (2018). New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity. Bioorganic Chemistry. 82. 360–377. 52 indexed citations
16.
Abdel‐Aziz, Mohamed, et al.. (2017). New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability. Bioorganic Chemistry. 74. 15–29. 51 indexed citations
17.
18.
Aboelez, Moustafa O., et al.. (2016). Design, Synthesis and Hypolipidemic Activity of Novel Hydrazones of Nicotinic acid Hydrazide. 2(3). 147–151. 5 indexed citations
19.
Hadimani, Mallinath B., et al.. (2015). Ring expansions of acyloxy nitroso compounds. Tetrahedron Letters. 56(43). 5870–5873. 11 indexed citations
20.
Shoman, Mai E., Jenna F. DuMond, Omar M. Aly, et al.. (2013). Direct and Nitroxyl (HNO)-Mediated Reactions of Acyloxy Nitroso Compounds with the Thiol-Containing Proteins Glyceraldehyde 3-Phosphate Dehydrogenase and Alkyl Hydroperoxide Reductase Subunit C. Journal of Medicinal Chemistry. 56(17). 6583–6592. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Boisbrun Breakdown of academic impact, for papers by Luigi Margarucci Breakdown of academic impact, for papers by Süreyya Ölgen Breakdown of academic impact, for papers by Ghaneya S. Hassan Breakdown of academic impact, for papers by Krishnendu Bera Breakdown of academic impact, for papers by Zeki Topçu Breakdown of academic impact, for papers by Piotr Świątek Breakdown of academic impact, for papers by Shahid M. Nayeem Breakdown of academic impact, for papers by Laura Guasch Breakdown of academic impact, for papers by Marco Tatò
Rankless by CCL
2026